Trial Profile
A Randomized, Open-label, Multiple Dosing, 3-way Crossover Study to Evaluate the Drug-drug Interaction Between Atorvastatin and Fenofibric Acid in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Fenofibric-acid (Primary)
- Indications Cardiovascular disorders; Diabetic nephropathies; Heart failure; Hypercholesterolaemia; Hyperlipoproteinaemia type IIa; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Low HDL cholesterol
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 07 Aug 2017 Status changed from recruiting to completed.
- 23 Apr 2015 New trial record